Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

Methods and materials for assessing response to plasmablast- and plasma cell-depleting therapies

US Patent 11613586 · Granted Mar 28, 2023

Estimated economic value: $81,489,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for assessing response to plasmablast- and plasma cell-dep2025
Methods and materials for assessing response to plasmablast- and plasma cell-dep2025
Methods and materials for assessing response to plasmablast- and plasma cell-dep2025
Use of cannabinoids in the treatment of epilepsy2023
Use of cannabinoids in the treatment of epilepsy2021
Therapeutic polypeptides, nucleic acids encoding same, and methods of use2005
Proteins and nucleic acids encoding same2005